Latest news
Arcus Biosciences (RCUS) Stock Gets Fair Value Bump After Casdatifan Optimism - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 05:10:00 GMTArcus Biosciences (NYSE: RCUS) gets 24.7% ownership from Gilead - Stock TitanStock Titan · Fri, 07 Aug 2026 20:31:22 GMTArcus Biosciences Inc (RCUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKeyTradingKey · Fri, 07 Aug 2026 09:26:20 GMTArcus Biosciences (NYSE:RCUS) Price Target Raised to $26.00 - MarketBeatMarketBeat · Thu, 06 Aug 2026 18:32:26 GMTRCUS Maintained by Wedbush -- Price Target Raised to $43.00 - GuruFocusGuruFocus · Thu, 06 Aug 2026 18:27:16 GMTArcus Biosciences, Inc. Stock 12‑Month Price Target Raised to $38.25, Implies 38% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:44 GMTWedbush Adjusts Price Target on Arcus Biosciences to $43 From $41, Maintains Outperform Rating - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:01:07 GMTArcus Biosciences, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:30:00 GMT